AI-Driven Drug Design: Agentic Reasoning for Biologics Targeting Disordered Proteins

Research#Agent AI🔬 Research|Analyzed: Jan 10, 2026 10:16•
Published: Dec 17, 2025 19:55
•
1 min read
•ArXiv

Analysis

This ArXiv paper highlights a potentially significant application of agentic AI in a complex domain. The use of AI for designing biologics, particularly those targeting intrinsically disordered proteins, suggests advancements in computational drug discovery.
Reference / Citation
View Original
"The paper focuses on scalable agentic reasoning for designing biologics."
A
ArXivDec 17, 2025 19:55
* Cited for critical analysis under Article 32.
Older

AI Advances Fungal Biodiversity Research with State-Space Models

Newer

DSO: Direct Steering Optimization for Bias Mitigation - A New Approach

Related Analysis

Research

Human AI Detection

Jan 4, 2026 05:47

Research

Deep Learning Book Implementation Focus

Jan 4, 2026 05:49

Research

Personalizing Gemini

Jan 4, 2026 05:49

Source: ArXiv